Remove tag ratio-therapeutics
article thumbnail

TG Therapeutics challenges Roche with FDA filing for CLL drug

pharmaphorum

US biotech TG Therapeutics has begun a rolling filing with the FDA for its combination therapy for chronic lymphocytic leukaemia, in a challenge to Roche. The trial continued enrolment in a 1:1 ratio into the two combination arms: the investigational arm of U2 and the control arm of obinutuzumab plus chlorambucil.

Drugs 52
article thumbnail

Clover Biopharmaceuticals Announces Publication of Phase 1 Clinical Trial Data for its Adjuvanted COVID-19 Vaccine Candidates in The Lancet

The Pharma Data

In both adults and elderly subjects, the vaccine candidates were safe and elicited cellular immune responses and high neutralizing antibody titers with a favorable ratio of neutralizing/binding antibodies. About Trimer-Tag© Technology. . CHENGDU, China , Feb. —- End —-. About S-Trimer COVID-19 Vaccine Candidate.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Unveiling Potential: Exploring Alpha Emitter Radiopharmaceuticals

XTalks

Therapeutic radiopharmaceuticals are particularly used in the treatment of cancer. Therapeutic radiopharmaceuticals deliver beta or alpha radiation, which destroys diseased cells, such as cancer cells. billion influx into radiopharmaceuticals which underscores the potential and robust growth in this therapeutic area.

DNA 66
article thumbnail

Perfusion MRI and Other Perfusion Imaging Techniques for Clinical Trials

XTalks

However, the role of MRI in new drug clinical trials can involve diagnosis of lesions and determination of their severity, early identification of therapeutic responders to drug treatment and treatment monitoring and follow-up. For most of this time, MRI mainly was used for qualitative interpretation and simple structural measurements.